Irinotecan Hydrochloride is a potent topoisomerase I inhibitor belonging to the camptothecin class, primarily used to treat metastatic colorectal cancer, often as part of the FOLFIRI chemotherapy regimen.… Read more
Irinotecan Hydrochloride is a potent topoisomerase I inhibitor belonging to the camptothecin class, primarily used to treat metastatic colorectal cancer, often as part of the FOLFIRI chemotherapy regimen. By stabilizing the DNA-topoisomerase I complex, the drug prevents DNA relaxation and replication within cancer cells. Pharmaceutical laboratories utilize this category of compounds, including high-quality reference standards, to support rigorous analytical testing and method validation. The selection encompasses essential materials for impurity profiling, such as pharmacopeial and non-pharmacopeial impurities, alongside stable isotope labelled compounds that serve as internal standards for quantitative analysis. These analytical tools are vital for ensuring accurate characterization, consistency, and quality control during the development and manufacturing of pharmaceutical products, allowing researchers to detect degradation products and metabolic pathways with precision.